A significant advancement for JetPeel™ technology: The manufacturer TavTech has successfully completed the MDR review process under the EU Medical Device Regulation (MDR) – one of the strictest regulatory standards for medical devices in Europe.
This comprehensively confirmed central requirements for quality, safety, and development and production processes by an officially accredited and EU-designated certification body.
The MDR certification of individual product families is carried out in stages. Initial applications have already been successfully certified, while the JetPeel™ product family is being specifically prepared for final MDR certification. Implementation is planned for summer 2026.
Particularly noteworthy: TavTech initiated this demanding process approximately three years before the expiry of the transitional periods. With the complete replacement of the previous directive (MDD) by the MDR, the requirements for medical devices in Europe are significantly increasing – a decisive step towards even higher device safety and sustainable market quality.
For users, partners, and customers, this primarily means one thing: long-term security, reliability, and a technology partner who not only meets regulatory standards but also thinks ahead early.
The next steps for the full MDR certification of the original JetPeel™ systems have already been initiated – underscoring the consistent commitment to remain among the leading technologies in the European market in the future.
Are you interested in JetPeel™? Let our sales team advise you.
